Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion type Assertion NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_head.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion description "[Due to its restricted expression pattern and immunogenicity FAM46D represents a novel target for cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_provenance.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion evidence source_evidence_literature NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_provenance.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion SIO_000772 19540335 NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_provenance.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion wasDerivedFrom befree-20150227 NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_provenance.
- NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_assertion wasGeneratedBy ECO_0000203 NP978070.RAwyuesNSj0FupsZ_9NAmZ4paR58H4P4D1dvQc4qtq-dk130_provenance.